✦ LIBER ✦

917 Improvement in quality of life is similar in anaemic patients with solid tumours and lymphoid malignancies treated with epoetin beta

✍ Scribed by M. Boogaerts

Book ID: 118621083
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 160 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90944-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-weekly epoetin beta is highly effec

Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production

✍ Mario Cazzola 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

P-680 Quality of life and fatigue improv

P-680 Quality of life and fatigue improvement in patients with thoracic malignancy treated with corticosteroids

✍ Rogers, Trevor K.; Hatton, Matthew Q.; Fernando, Justin M.; Pirzada, Omar M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Epoetin alfa corrects anemia and improve

Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy

✍ Timothy J. Littlewood; Johan Nortier; Bernardo Rapoport; Marek Pawlicki; Gilbert 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Anemia, a commonly occurring morbidity in patients with cancer, often leads to diminished quality of life (QOL). Numerous clinical trials have shown that epoetin alfa treatment improves hematologic and QOL variables in cancer patients. The clinical trial analysis reported here was performed to asses

Early intervention with epoetin alfa tre

Early intervention with epoetin alfa treats anaemia and improves quality of life in ovarian cancer patients undergoing chemotherapy

✍ P.M. Wilkinson; H. Andersson; M. Antonopoulos; M. Lahousen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Long-term agalsidase beta therapy is ass

Long-term agalsidase beta therapy is associated with improvements in pain and quality of life among patients with Fabry disease

✍ N. Guffon; D.P. Germain; S. Waldek; M. Banikazemi; D.A. Bushinsky; J. Charrow; P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 122 KB

AOS26 Bevacizumab-induced hypertension a

AOS26 Bevacizumab-induced hypertension and use of anti-hypertensive drugs is associated with improved outcome in patients with solid organ tumours treated with bevacizumab

✍ C.S. Tan; W. Ling; T. Soh; A. Pang; P.J. Voon; S.C. Lee 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB